医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Promega Introduces MethylEdge™ Bisulfite Conversion System for DNA Methylation Analysis

2013年02月12日 PM09:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Promega MethylEdge(TM) Bisulfite Conversion System converts small amounts of DNA efficiently while maintaining DNA integrity in less than two hours. (Photo: Business Wire)Promega MethylEdge(TM) Bisulfite Conversion System converts small amounts of DNA efficiently while maintaining DNA integrity in less than two hours. (Photo: Business Wire)

View and Share Photo

Close Window


MADISON, Wis.

Promega Corporation announced today that it has launched MethylEdge™ Bisulfite Conversion System. The system offers an efficient method for rapidly performing bisulfite conversion and DNA clean-up within two hours, while maintaining DNA integrity to provide more intact, converted DNA for a variety of sensitive applications.

Promega MethylEdge(TM) Bisulfite Conversion System converts small amounts of DNA efficiently while m ...

Promega MethylEdge(TM) Bisulfite Conversion System converts small amounts of DNA efficiently while maintaining DNA integrity in less than two hours. (Photo: Business Wire)

MethylEdge requires only small amounts of input genomic DNA (100pg-2µg). Using optimized conversion reagents, clean-up and recovery methods, the system converts DNA at ≥90% efficiency with minimal fragmentation. The resulting DNA is suitable for use in downstream applications such as PCR, array, or sequencing assays.

The kit includes all reagents necessary to perform 50 bisulfite conversion reactions. All MethylEdge reagents can be stored at room temperature and require minimal up-front preparation. Control DNAs are also available separately and can be used as standards in both the conversion reaction and post-conversion analysis.

The Promega MethylEdge Bisulfite Conversion System complements Promega nucleic acid purification kits for a wide variety of sample types and throughput levels, quantitation chemistries for both pre- and post-conversion, and Promega amplification technologies for detection, providing a quality workflow solution to DNA methylation sample preparation.

For more information please visit: www.promega.com/methylation

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130212005360/en/

CONTACT

Promega Corporation
Penny Patterson
Sr. Director,
Communications
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com
or
Zyme
Communications Ltd
Katie Odgaard
Tel: +44 (0) 7787 502 947
Skype:
kodgaard
Email: katie.odgaard@zymecommunications.com
www.zymecommunications.com

同じカテゴリーの記事 

  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究